Both in Pharmaceuticals
Tempest Therapeutics vs GT Biopharma
Over the past year TPST returned −90.1% and GTBP returned −65.8%; their daily moves had a correlation of 0.02.
TPST −90.1% GTBP −65.8%Growth of $1, one year, split-adjusted
| Metric | TPST | GTBP |
|---|---|---|
| Price | $0.4955 | $5.32 |
| Market cap | $9.9M | $9.6M |
| Today | −7.07% | −5.00% |
| 1 month | −38.5% | −14.2% |
| 6 months | −75.7% | −38.0% |
| Year to date | −65.5% | −72.9% |
| 1 year | −90.8% | −64.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $779.0K | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 157.4% | 958.3% |
| Short % of float | 3.1% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).